Home LiteratureArticle Details
PMID: 21798894 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Science (New York, N.Y.) ·Vol. 333 ·No. 6044 ·2011-08-12 ·Pages 850-6

Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A

Abstract

The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated a neutralizing monoclonal antibody that recognized the hemagglutinin (HA) glycoprotein of all 16 subtypes and neutralized both group 1 and group 2 influenza A viruses. Passive transfer of this antibody conferred protection to mice and ferrets. Complexes with HAs from the group 1 H1 and the group 2 H3 subtypes analyzed by x-ray crystallography showed that the antibody bound to a conserved epitope in the F subdomain. This antibody may be used for passive protection and to inform vaccine design because of its broad specificity and neutralization potency.

MeSH Terms
Animals Antibodies, Neutralizing/immunology,isolation & purification Antibodies, Viral/immunology,isolation & purification Antibody Specificity Antigens, Viral/immunology Cells, Cultured Cross Reactions Crystallography, X-Ray Epitopes/immunology Ferrets Glycosylation Hemagglutinin Glycoproteins, Influenza Virus/immunology Humans Hydrophobic and Hydrophilic Interactions Immunization, Passive Immunoglobulin Variable Region/immunology Influenza A Virus, H1N1 Subtype/immunology Influenza A virus/immunology Influenza B virus/immunology Influenza, Human/immunology Mice Models, Molecular Molecular Sequence Data Orthomyxoviridae Infections/immunology,prevention & control,therapy Plasma Cells/immunology Protein Multimerization Protein Structure, Secondary
Chemicals
Antibodies, Neutralizing Antibodies, Viral Antigens, Viral Epitopes Hemagglutinin Glycoproteins, Influenza Virus Immunoglobulin Variable Region
Authors & Affiliations
23 authors, click to expand affiliations / ORCID
Corti Davide
Institute for Research in Biomedicine, 6500 Bellinzona, Switzerland.
Voss Jarrod
Gamblin Steven J
Codoni Giosiana
Macagno Annalisa
Jarrossay David
Vachieri Sebastien G
Pinna Debora
Minola Andrea
Vanzetta Fabrizia
Silacci Chiara
Fernandez-Rodriguez Blanca M
Agatic Gloria
Bianchi Siro
Giacchetto-Sasselli Isabella
Calder Lesley
Sallusto Federica
Collins Patrick
Haire Lesley F
Temperton Nigel
Langedijk Johannes P M
Skehel John J
Lanzavecchia Antonio
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
1095-9203
Published
2011-08-12
Epub
2011-00-28
Pages
850-6
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Grants
European Research Council · 250348 · International
Medical Research Council · G0600369 · United Kingdom
Medical Research Council · MC_U117584222 · United Kingdom
Wellcome Trust · United Kingdom
Databases
GENBANK
JN234430, JN234431, JN234432, JN234433, JN234434, JN234435, JN234436, JN234437, JN234438, JN234439, JN234440, JN234441, JN234442, JN234443, JN234444, JN234445, JN234446, JN234447, JN234448
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com